Governance is a precondition, not a footnote.
Structured review, transparent evidence and documented workflows form the operating model of VisaVault Lifescience.
Scientific review
Every scientific item passes structured internal review before any public communication.
Legal review
Compliance-sensitive content requires documented legal review prior to publication.
Evidence transparency
Limitations, conflicts of interest and evidence levels are disclosed alongside every claim.
Publication workflow
Items move through Draft → Internal Review → Scientific Review → Legal Review → Approved → Published.
How governance is practiced, step by step.
The four pillars above describe what we commit to. The workflow on the right describes how each commitment is carried out before any content reaches the public site — and what guarantees we make to readers, partners and reviewers.
We never present any compound, sequence or formulation as intended for human use, diagnosis, treatment, prevention or cure.
Every research item carries explicit limitations: model boundaries, sample sizes, missing replication and unresolved methodological questions.
Analytical, academic and laboratory partners are engaged through written agreements with documented scope and quality expectations.
If new evidence contradicts a published item, the workflow supports rapid retraction, correction or re-grading with audit trail.
- 01Draft
Authoring team prepares the initial editorial or scientific item with sources, limitations and evidence level annotations.
- 02Internal Review
Cross-functional peer reading checks scope, terminology, claims and tone against the editorial framework.
- 03Scientific Review
A qualified reviewer validates methodology, references, evidence grading and the boundary between description and recommendation.
- 04Legal Review
Compliance review for applicable jurisdictional, advertising, research-use and consumer-protection requirements.
- 05Approved
Item is signed off, archived with version metadata and made eligible for publication on the public site.
- 06Published
Released with attribution, evidence-level badge and a documented reversal path if information later changes.
These workflows describe the intended governance model of VisaVault Lifescience and form the binding internal standard for editorial and scientific output. They do not constitute regulatory approval, do not certify any specific compound, and do not substitute for qualified clinical, legal or regulatory consultation.